FGF23 and chronic kidney disease: In addition, our results may shed light on the mechanisms involved in the pathogenesis of CKD-induced CVD and clarify, in a clinical setting, the links between mTOR activation and other relevant regulatory systems in aging biology as klotho/FGF23 axis and mitochondrial function/biogenesis.